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Abstract: Bioengineering holds great promise to provide fast and efficient biocatalysts for
methanol-based biotechnology, but necessitates proven methods to optimize physiology in
engineered strains. Here, we highlight experimental evolution as an effective means for
optimizing an engineered Methylobacterium extorquens AM1. Replacement of the native
formaldehyde oxidation pathway with a functional analog substantially decreased growth
in an engineered Methylobacterium, but growth rapidly recovered after six hundred
generations of evolution on methanol. We used whole-genome sequencing to identify the
basis of adaptation in eight replicate evolved strains, and examined genomic changes in
light of other growth and physiological data. We observed great variety in the numbers and
types of mutations that occurred, including instances of parallel mutations at targets that
may have been “rationalized” by the bioengineer, plus other “illogical” mutations that
demonstrate the ability of evolution to expose unforeseen optimization solutions. Notably,
we investigated mutations to RNA polymerase, which provided a massive growth benefit
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but are linked to highly aberrant transcriptional profiles. Overall, we highlight the power of
experimental evolution to present genetic and physiological solutions for strain
optimization, particularly in systems where the challenges of engineering are too many or
too difficult to overcome via traditional engineering methods.
Keywords: Methylobacterium; bioengineering;
sequencing; RNA polymerase; C1 metabolism

experimental

evolution;

genome

1. Introduction
Methylobacterium strains have emerged as premier biocatalysts for methanol-based biotechnology.
Tools for metabolic engineering [1–6], metabolic models [7–9], systems-level assays of
physiology [5,10], whole-genome sequences [11,12], and a rich, 55 year history of research [13] have
positioned this genus as a key model system for converting methanol into value-added products. As a
facultative methylotroph, Methylobacterium strains are able to grow on both reduced one-carbon (C1)
compounds like methanol, as well as multi-C compounds like succinate. Primarily using methanol as a
feedstock, Methylobacterium has thus far been engineered to produce a variety of compounds [14],
including polyhydroxybutyrate derivatives [15], amino acids [16], butanol [17], and various
proteins [18,19]. Despite the many advantages of methanol and Methylobacterium, research in this
area is still in its infancy, and further exemplars are needed to validate Methylobacterium as a flexible
and practical solution for biotechnology.
The demands of bioengineering can place considerable stress on cells, and identifying the root cause
of the underlying physiological stressors and inefficiencies can prove difficult [20]. Once these
challenges are identified, they can be overcome using further engineering methods or directed
evolution (i.e., artificial selection of artificially-generated mutants) at target loci to optimize the
engineered physiology. However, when the challenges of bioengineering are difficult to identify, or
too extensive to optimize through “rational” engineering, experimental evolution offers a productive
route toward strain improvement. In most experimental evolution regimes, mutants are allowed to arise
naturally in serially transferred cultures, and either increase or decrease in frequency in populations
due to natural selection for increased growth rate [21,22]. In M. extorquens AM1, experimental
evolution has been successfully employed to study fundamental questions in evolution [23–26], and to
optimize strains engineered with alternate codon usage [27], or conferred with the ability to metabolize
dichloromethane [28]. However, one avenue of research that would greatly facilitate the development of
Methylobacterium-based biotechnology would be to establish the use of experimental evolution as an
effective method for strain optimization: To directly optimize bacterial growth, to “diagnose”
physiological stressors and inefficiencies from strain construction, and to present genetic and
physiological mechanisms by which these challenges are overcome.
A model system has been developed to investigate the physiological consequences of metabolic
engineering in a strain of M. extorquens AM1 with a major overhaul of C1 metabolism. In wild-type
(WT) M. extorquens grown on methanol, methanol dehydrogenase produces formaldehyde as a highly
toxic metabolic intermediate, which is quickly oxidized through a series of reactions to formate using
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the cofactor tetrahydromethanopterin (H4MPT) [29,30]. Formate can then be oxidized to CO2 for
reducing power [31,32], or assimilated into biomass via tetrahydrofolate-mediated reactions and the
serine cycle [7,33,34]. Construction of an engineered Methylobacterium (EM) strain involved
eliminating the H4MPT pathway, then expressing a new pathway for formaldehyde oxidation in its
place [25]. To accomplish this change, we deleted the first dedicated enzyme for the synthesis of
H4MPT, and introduced a plasmid (pCM410) expressing two genes—flhA, encoding
S-hydroxymethylglutathione dehydrogenase [35]; and fghA, encoding S-formylglutathione
hydrolase [36]—from Paracoccus denitrificans. These enzymes co-opt glutathione (GSH), an
endogenous cofactor in most bacteria, such that it now serves as the major formaldehyde carrier. By
itself, the strain lacking H4MPT is unable to grow on methanol; however, the heterologous expression of
flhA and fghA permitted growth on methanol via GSH, albeit three-fold more slowly [25]. Subsequent
work sought to understand what, exactly, is limiting growth in the EM strain, and how it could be
improved using experimental evolution in the laboratory.
Experimental evolution was carried out by inoculating 8 replicate flasks with EM and propagating
these cultures via serial transfer on methanol for over 600 generations. Adaptation in these evolved “F”
populations was both rapid and pronounced, resulting in strains that were up to 2.5-fold faster than EM
by generation 600 (G600) [10]. Improvements were also most pronounced on methanol and
methylamine versus other growth substrates, suggesting only minor optimization towards general
growth conditions [10,25].
A number of studies have dissected aspects of the genetic and physiological basis of growth
improvement in the evolved F strains, and these included a couple cases of highly parallel evolution.
The most direct adaptation in the F strains was to lessen the burden of expressing the engineered
pathway itself. While this pathway is essential in EM for growth on methanol, its initial expression
level from the methanol dehydrogenase promoter was far too high. This led to selection for a
menagerie of mutations that decreased expression in a variety of ways [37]. These rose in frequency in
all F populations, and 8/8 of the strains examined here possessed one such change. The second
example of a high degree of parallelism emerged upon discovering that the medium used for evolution
was cobalt-limiting [38,39]. It was found that 6/8 F populations had IS insertions upstream of a novel
transporter, icuAB, as had another 24/24 populations of WT evolved in separate experiments with
methanol [39].
In addition to knowledge of parallel mutations at a couple loci, one study that fully sequenced the
genome of an F4 isolate revealed a number of adaptations in host physiology [25]. Notable changes
included mutations to gshA (encoding -glutamylcysteine ligase), which drives the second-to-last step
in the synthesis of GSH; and to pntAB (encoding pyridine nucleotide transhydrogenase), that drives the
proton-driven interconversion of NAD(H) and NADP(H); both mutations were found to be highly
beneficial, and each increased the expression of these genes due to satisfy the cellular demands for
GSH and NADPH, respectively.
To begin to connect evolved genotypes to phenotypes, DNA microarrays were used to examine both
gene-by-gene and global patterns of transcriptional change from WT, to EM, to evolved isolates from
each of the 8 F populations [10]. While the overarching trend for the F strains was to “restore”
WT-like expression from a perturbed, EM transcriptional state, several large-scale differences in the
evolved expression profiles were noted, causing strains F1, F4, and F8 to cluster away from other F
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strains in a principal component analysis. For F4, an extraordinary number of “novel” decreases in
expression were found to stem from a loss of roughly 617 kilobases through a large-scale
deletion [25,40]; upon the exclusion of these deleted genes, the expression profile of F4 was similar to
that of other F isolates. For F1 and F8, however, we observed a large number of truly “novel” changes
in gene expression relative to EM, and the cause for these unique transcriptional profiles was not
immediately clear. For these and the remaining F lines, knowledge of the mutations that occurred
could greatly aid our understanding of evolved physiologies.
Here, we expand whole-genome re-sequencing to reveal the genomic basis of host adaptation in the
remaining F strains. In light of these sequences, we investigate broad-level variation in the number and
types of mutations across F strains, targets that were mutated in parallel across lineages, loci that are of
particular interest to M. extorquens physiology and C1 metabolism, and connections between genome
sequences and global expression data from microarray analyses. Finally, we provide an in-depth
analysis of mutations to RNA polymerase in strains F1 and F8, which appear to offer highly beneficial,
yet massively pleiotropic changes in gene expression. Overall, our work draws attention to the
usefulness of experimental evolution for Methylobacterium-based bioengineering: To optimize strain
growth and physiology, to “diagnose” physiological stressors and inefficiencies from engineering, and as
a means to discover novel connections between the M. extorquens genome, cellular physiology, and
C1 metabolism.
2. Materials and Methods
2.1. Strain Construction and Evolution Regime
All strains and plasmids used in this study are listed in Table S1. All mutants were derived from a
pink-pigmented, “wild-type” laboratory strain of M. extorquens AM1 (CM501), and a white-colored
strain (CM502) with a neutral mutation in carotenoid biosynthesis [3]. From these WT strains, pink
(CM701) and white (CM702) EM strains were designed by: (1) disabling the native H4MPT-based
pathway of formaldehyde by deleting mptG, encoding -ribofuranosylaminobenzene 5′-phosphate
synthase, the first committed step in the synthesis of the H4MPT cofactor [41]; and (2) introducing
plasmid pCM410 expressing the flhA (encoding S-hydroxymethyl-GSH dehdyrogenase) and fghA
(encoding S-formyl-GSH hydrolase) genes from Paracoccus denitrificans [25].
Eight replicate “F” populations—F1 through F8—were founded from either the pink CM701 (odd)
or white CM702 (even) EM ancestors, and propagated in 9.6 mL of Hypho medium in 50 mL
Erlenmeyer flasks with 15 mM methanol at 30 °C and 225 rpm for over 600 generations [25].
Populations were streaked at various time points to check for contamination, and were frozen, along
with isolates, to keep a “living fossil record” of the evolution experiment. An isolate from each
evolved population at G600 was chosen for in-depth physiological analyses [10] and whole-genome
sequencing (described below).
Other strains were generated as follows. Mutations from evolved F isolates were moved into their
ancestral EM and other genetic backgrounds using pCM433, a tetracycline-based “suicide” vector for
allelic exchange mediated by homologous recombination [3]. For each allelic exchange construct, a
PCR product was designed to amplify the mutation plus roughly 500 bp upstream and downstream
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flanking regions from the evolved isolates in which they occurred. Amplicons were assembled into
pCM433 using Gibson isothermal assembly [42], and introduced into the host M. extorquens strain
using triparental conjugal matings with the helper plasmid pRK2073 [43]. After selection for
single- and double-crossover events [3], single colonies were isolated and screened for successful
incorporation of the mutation. For EM-based backgrounds, plasmid pCM410 was cured before allelic
exchange, and then was subsequently returned using triparental matings.
2.2. Growth Conditions and Measurement of Specific Growth Rate
Growth was performed using a modified Hypho minimal medium described in [25]. Liquid cultures
were grown using 10 mL Hypho in 50 mL Erlenmeyer flasks, plus the appropriate carbon substrate
added just prior to growth: Either methanol (20 mM) or succinate (3.5 mM). When necessary,
antibiotics were used at the following concentrations: Kanamycin, 50 μg/mL; tetracycline 12.5 μg/mL;
streptomycin, 100 μg/mL.
All growth measurements were performed using inoculation, acclimation, and experimental growth
phases. Briefly, all M. extorquens strains were inoculated from freezer stocks into flasks with 0.5×
methanol and 0.5× succinate to allow for robust growth. Upon growth saturation, flasks were
transferred to an acclimation phase growth with the carbon source to be tested (i.e., methanol only) in
either a flask or microtiter plate. Finally, acclimation cultures were transferred once more to the same
conditions for experimental measurements. The increase in optical density of cultures (OD600) over
time was monitored in 48-well microtiter plates using an automated, high-throughput growth
system [44], and the specific growth rate calculated from the exponential growth phase [45]. Cellulase
enzyme from Aspergillus niger (Sigma-Aldrich, St. Louis, MO, USA) was added to cultures at a
concentration of 0.1 mg/mL to minimize cell clumping and increase the accuracy of OD600
measurements [46]. Data points are plotted with the mean plus SEM for at least triplicate growth
measurements.
2.3. Stress Test with Hydrogen Peroxide
A stress test of strains against hydrogen peroxide was performed via a disk diffusion assay as
in [47]. All strains were grown to saturation in flasks with methanol and mixed 1:20 into soft agar
(0.75%) Hypho medium pre-warmed to 42 °C, and 4 mL of this cell suspension was evenly poured
onto the surface of normal Hypho agar (1.6%) plates with 125 mM methanol, +/− kanamycin. Plates
were allowed to solidify and dry, and then a small (5 mm), sterilized filter disc was added to directly to
the center. To this filter disc we added 5 μL of 10 M hydrogen peroxide, and incubated plates at 30 °C;
each strain was assayed in triplicate, and control plates received no hydrogen peroxide. After one week
of growth, we measured the diameter (cm) of growth inhibition caused by hydrogen peroxide stress,
and normalized values respective to each strain’s pink or white ancestor.
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2.4. Whole-Genome Re-Sequencing
Whole-genome re-sequencing of F populations isolates was performed as follows with the
exception of F4 (CM1145), which was sequenced previously [25]. Preparation of genomic DNA was
performed using phenol-chloroform extraction with isopropanol precipitation [48]. Sequencing was
performed out-of-house by GENEWIZ, Inc. (South Plainfield, NJ, USA) using Illumina HiSeq2000 to
produce 50 bp single-end reads. All data has been deposited to the NCBI Sequencing Read Archive
(PRJNA273781). Reads were mapped against an EM (CM701) reference genome using
breseq v0.21 [49] with Bowtie 2 v2.0.0-beta7 [50]. Mutations called by breseq were individually
assessed and those with marginal or conflicting quality (i.e., equal or greater mix of WT with the
mutant sequence reads) were excluded from downstream analyses. Other mutations that were shared
among all or most F strains were likely acquired in the construction of EM from WT, and were also
excluded [25]. Mutations to the foreign pathway and plasmid were identified previously [37], with the
exception of a mutation in flhA. All mutations identified in this study are listed in Table S2.
2.5. Analysis of Microarray Data
Analysis of microarray data was performed as described previously [10] to determine global gene
expression profiles in WT, EM, and isolates of each of the evolved (EVO) F strains. Briefly,
differentially expressed genes were identified using moderated t-test of values in EM/WT and
EM/EVO comparisons and assimilated across multiple probes per locus. These comparisons
distinguish changes in gene expression arising from the immediate, physiological acclimation to the
engineered pathway (EM/WT) from those arising from evolutionary changes in the F lineages
(EM/EVO). By creating a “reaction norm” of differentially expressed genes between WT, EM, and
each EVO strain, we identified 4 unique categories of gene expression change: (1) “novel” gene
expression, in which expression was unaltered in acclimation (EM/WT) but significantly different in
adaptation (EM/EVO); (2) “restored” patterns, in which expression was altered in EM/WT but
returned to WT levels in the EVO strain; (3) “unrestored” patterns, in which expression was altered in
EM/WT and remained unchanged in EVO; and (4) “reinforced” patterns, in which expression was
altered in EM/WT and then was exacerbated in the same direction in the EM/EVO comparison.
3. Results and Discussion
3.1. Overview of Genomic Changes at 600 Generations
We used whole-genome re-sequencing to identify the genomic changes in isolates from seven of the
F populations at G600 to examine general trends in F genome evolution. These data supplement the
previous information on the F4 isolate [25], mutations in the introduced pathway/plasmid [37], and in a
couple other loci that had been targeted [10]. First, we found that the number of mutations varied
across strains: From 4 in F2, to 18 in F8 (Table 1), including mutations to the foreign plasmid and
pathway [25,37]. The types of mutations ranged from SNPs, small insertions and deletions,
duplications, and the movement of transposable insertion sequence (IS) elements, which in the case of
F4 resulted in the deletion of some 617 kilobases through recombination between homologous ISs. In
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comparing the number of mutations in each strain to either the degree of growth improvement or novel
gene expression, we found no correlation (Figure S1).
Several genomic targets were mutated highly in parallel across the evolved F isolates (Table 2).
By far the most frequently mutated target was that of the engineered pathway and plasmid. As
mentioned above, prior work identified that 8/8 populations mutated the introduced plasmid in the EM
ancestor [37], and 6/8 F populations had an IS insertion at icuAB [25]. Through examining the
microarray data, we found that the only two evolved isolates lacking an icuAB mutation—F5 and F6—
did not increase the expression of this locus. We did, however, find in the whole-genome sequence of
F5 an IS insertion between a manganese/divalent metal cation transporter (mntH) and its
transcriptional regulator (mntR), which increases expression of the former (and decreases the latter) by
roughly four-fold. This transporter was found to be active with Cobalt(II) in Escherichia coli [51], and
might serve the same role as icuAB in this lineage.
Another commonly mutated locus was gshA, encoding -glutamylcysteine ligase, which carries out
the next-to-last step in GSH biosynthesis. Normally, GSH functions to protect the cell against
oxidative stressors. In EM, however, GSH was also co-opted as a carrier of C1-units during
formaldehyde oxidation, and is likely too dilute to efficiently carry out its native and engineered
functions. Prior work identified a beneficial mutation in gshA in F4 [25], and here we identified four
other mutations, including a gene duplication and a SNP roughly 2 kb upstream of gshA. All of these
are associated with significantly increased (and “novel”) gene expression relative to EM as revealed by
microarray analysis (Figure 1A) [10]. While mutations in the neighborhood of gshA appear in these
5/8 F strains, we also previously noted increased expression of gshA in F8 [10], suggesting that other
mutations might affect the expression of this locus in trans. One remaining strain (F7) acquired an
internal duplication to cysE—encoding serine acetyltransferase—which functions several reactions
upstream of GshA in the synthesis of cysteine, and might serve the same functional role.
The potassium:proton antiporter, kefB, was found to be mutated in 3/8 F lineages. In E. coli, KefB
activity is allosterically responsive to the GSH pool, whereby free GSH represses activity and oxidized
conjugates (like CH2OH-GSH) are activators, causing cytoplasmic acidification and protection from
oxidative stress [52,53]. In these evolved isolates (Figure 1B), it is unclear exactly how these missense
and nonsense mutations alter KefB function; the F5 allele, in particular, prematurely ends the synthesis
of KefB just before the GSH-binding regulatory domain. Each of these kefBEVO alleles was placed into
the ancestral, EM background and provided an average 23% benefit during growth on methanol
(Figure 1C). Similar mutations to kefB were identified in M. extorquens AM1 strains that were
experimentally evolved to use methylamine as a carbon source via the N-methylglutamate
pathway [54]. That allele was found to activate KefB activity and led to cytoplasmic acidification that
counterbalanced the release of ammonia from methylamine.
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Table 1. Summary of F population isolates at G600.

Population

Isolate

Growth Relative to EM 1

# Novel Expression 1

Total # Mutations

# Intergenic

# Coding

# IS Elements

F1
F2
F3
F4
F5
F6
F7
F8

CM1727
CM1730
CM1139
CM1145
CM1739
CM1742
CM1745
CM1748

1.96
2.15
2.44
2.50
2.09
2.09
2.16
2.11

149
12
17
217
42
47
21
197

11
4
11
9
11
11
9
18

2
2
5
4
5
2
2
8

8
1
5
4
5
8
6
8

2
1
2
2
6
3
2
6

1

Data from [10].

Table 2. Parallel evolution at specific genomic targets.

1

Isolate

pCM410

icuAB

gshA

META1_4902 1

kefB

rpoA

ATP Synthase 2

pntAB

META2_0008 3

META1_3102 4

F1
F2
F3
F4
F5
F6
F7
F8

+
+
+
+
+
+
+
+

+
+
+
+
−
−
+
+

−
+
+
+
+
+
−
−

+
−
+
+
−
−
−
−

−
−
−
−
+
+
−
+

+
−
−
−
−
−
−
+

+
−
+
−
−
−
−
−

−
−
+
+
−
−
−
−

−
−
+
−
+
−
−
−

−
−
−
−
−
−
+
+

Putative membrane protein; ATPase; 2 Mutation to atpI in F1; atpF in F3; 3 Putative beta-ketoacyl synthase; 4 conserved hypothetical protein, putative cAMP-binding domain-like.
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Figure 1. Parallel mutations to gshA and kefB occurred in multiple F lines. (A) Multiple mutations that appear to account for the observed
increase in expression of gshA. Shown are evolved gshA alleles and increases in gene expression (bold) from microarray analysis. (B) The
kefB locus was also targeted by parallel mutations in multiple F lines, and (C) each evolved allele was found to be beneficial in the EM
background grown on methanol. Asterisk (*) indicates p < 0.05 in a two-tailed, unpaired t-test assuming unequal variance.
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Finally, a number of other interesting loci were identified in only one or two evolved strains. As
was noted previously, pntAB (encoding a pyridine nucleotide transhydrogenase) was mutated in 2/8
lineages to increase production of NADPH. Without H4MPT, neither of the methylene-H4MPT
dehydrogenases can generate NADPH for the cell, making transhydrogenase essential for
methylotrophy. Interestingly, we identified a 12 bp deletion within the coding frame of mtdB in strain
F2, despite this locus having no known enzymatic role in the engineered formaldehyde oxidation
pathway. It is not yet known whether this evolved mtdB allele was beneficial for optimizing EM
physiology, or simply the result of relaxed selection due to disuse (i.e., genetic drift). Other striking
genomic changes included mutations to two different components of ATP synthase in F1 (atpI) and F3
(atpF); in F1, a mutation to glycine decarboxylase (gcvP) which, as part of the glycine cleavage
system, was one of the largest changes in gene expression from WT to EM that remained unrestored in
the evolved lineages [10]; mutations to lysine (F7) and leucine (F8) tRNAs; and finally, mutations to
the alpha subunit of RNA polymerase in F1 and F8, which we explore in greater detail below.
3.2. Unique Expression Profiles Linked to Mutations in RNA Polymerase
Prior work with DNA microarrays identified two evolved strains—F1 and F8—with highly
divergent transcriptional profiles, however the cause for these unique transcriptional profiles was not
immediately clear. Here, we identified a major candidate to explain this altered gene expression in
mutations to the alpha subunit of RNAP, encoded by rpoA. Given its central role in DNA transcription,
RNA polymerase (RNAP) has far-reaching control over global mRNA levels, and changes to this
enzyme complex would be expected to have highly pleiotropic and generally deleterious effects. F1 and
F8 acquired independent internal duplications in rpoA that extend the protein product by 77 (F1) or
32 (F8) amino acids (Figure 2A). Homology to more well-characterized RpoA proteins suggests that
these mutations extend an unstructured linker region connecting two distinct RpoA domains: The
N-terminal domain (NTD) that helps to assemble the rest of the RNAP holozyme; and a C-terminal
domain (CTD) that binds to upstream promoter (UP) elements at target genes (Figure 2B). It is
important to note, however, that extension of the linker is not perfect, and small portions of the
neighboring domains are duplicated in both instances. While uncovering the exact biochemical effects
of these mutations will require substantial future work, a broad hypothesis is that extensions of the
linker domain change interactions between the NTD of RNAP and gene-specific UP elements,
altering gene expression at some loci, such as several A-rich regulatory sequences that were identified
upstream of various C1-related genes [55]. Mutations to the rpoA linker have been shown to alter gene
expression in other systems, and have varying effects across different types of promoter
elements [56,57]. In light of these rpoA mutations, we revisited our previously generated microarray
data for unique patterns of gene expression in strains F1 and F8.
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Figure 2. Mutations that extend the RNAP linker are linked to unique gene expression in
F1 and F8. (A) Wild-type RpoA consists of NTD and CTD domains connected by an
unstructured linker. F1 and F8 possess internal sequence duplications (black bar) that are
hypothesized to extend both the linker and neighboring domains. (B) Bacterial RNAP is
composed of five core subunits. Important to this work are the effects of linker extension
mutations on the NTD and the CTD, which facilitate binding to DNA and co-regulatory
proteins near UP binding sites. Modified from [58]. (C) F1 and F8 have up to 16-fold more
genes with “novel” expression [10], most of which are uniquely shared between only these
two strains relative to other F strains.
The most unique feature of the transcriptomes of F1 and F8 was hundreds of instances of “novel”
gene expression relative to other F strains. In light of newly found mutations to rpoA, we sought to
reexamine these instances of novel expression in F1 and F8, to identify what proportion of these genes
are both shared and novel in only these strains. Across genes with novel expression in F1 (n = 149) and
F8 (n = 197), we found that the vast majority was shared between these and no other F strain
(Figure 2C). These genes include a number of interesting functions, with most involved in C1
metabolism, DNA replication and repair, and the stress response (Table 3). A fairly large proportion of
genes that were novel in only F1 or F8 could be due to mutations (or alleles) unique to each strain,
differences in rpoAEVO alleles, or simply marginally (in)significant differences in gene expression
identified in the microarray analysis. Finally, only a small handful of genes with novel expression were
shared between these and other F strains. Given that many C1-related genes are uniquely differentially
expressed only in these rpoAEVO strains, including genes like mauF (methylamine utilization)—which
plays no known role in methanol oxidation—it is possible that rpoAEVO acts predominantly with
higher-level regulators of cellular growth and C1-metabolism.
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Table 3. Gene expression divergence in strains with rpoAEVO mutations.
Expression

Exp F1 2

Exp F8 2

Exp Others 2,3

Novel

−2.23

−2.14

−1.21

Hsp70 chaperone protein

Novel

2.41

2.06

−1.02

DNA polymerase

Novel

2.68

2.46

1.22

Novel

5.17

4.06

1.33

Gene

Locus

Function

recO

META1_0821

DNA repair

dnaK

META2_0894

polA

META2_0971

META1_2781

META1_2781

putative antioxidant enzyme;
Tpx-related thiol peroxidase

Change 1

xoxF

META1_1740

C1 metabolism/regulation

Novel

6.32

5.70

1.38

mxbD

META1_1753

C1 metabolism/regulation

Novel

−1.78

−1.96

1.00

fdh4A

META1_2094

C1 metabolism

Novel

−8.28

−8.28

−1.85

mauF

META1_2769

C1 metabolism

Novel

7.57

6.41

1.55

gap

META1_2218

PHB biosynthesis

Novel

−3.71

−3.94

−2.27

META1_0222

META1_0222

putative sensor histidine kinase

Unrestored

1.31

1.09

1.79

def

META1_1530

peptide deformylase

Restored

2.17

2.83

1.47

ibpA

META1_1514

heat shock protein

Restored

−2.53

−3.14

−1.61

META1_4113

META1_4113

Restored

−18.13

−10.34

−3.34

META1_5150

META1_5150

Restored

−35.75

−31.56

−2.69

1

hypothetical protein; putative
sarcosine oxidase-related
hypothetical protein

As defined in “Materials and Methods” and [10]: “Novel” expression is significantly different in a comparison of EVO/EM but not

EM/WT; “restored” expression is altered in EM/WT and returns to WT levels in EVO/EM; “unrestored” is altered in EM/WT and remains
unchanged in EVO/EM; 2 Average fold change relative to EM. −, decrease in expression; 3 Excludes instances of F4 gene deletions.

Furthermore, we found that F1 and F8 uniquely restored WT gene expression. In contrast to strictly
“novel” changes that arise solely from adaptation, we previously identified a set of 455 genes whose
expression was perturbed during the physiological acclimation of EM from WT, and were either
restored, unrestored, or reinforced through F evolution [10]. While all F lines generally restored
perturbations in EM to WT expression, we found many instances where the magnitude of change
differed in F1 and F8 relative to other F lines (Table 3). Notably, a number of genes were more
strongly restored—versus only partially restored or unrestored—than other F strains. Our results
suggest that, for a common set of gene expression changes that were caused by the genetic changes
from WT to EM, F1 and F8 coped with these perturbations in slightly different, and perhaps more
effective way.
3.3. Investigation of Conditions under which rpoAEVO Was Advantageous
The presence of nearly identical rpoA mutations in two independently evolved populations strongly
suggested that these genomic changes were beneficial for growth of EM on methanol. To confirm and
quantify the potential benefit of these mutations, we used allelic exchange to transfer the alleles from
F1 and F8 into the ancestral, EM background, and measured growth in these strains. However, as is
often the case, the effect of beneficial mutations can be limited to particular genetic backgrounds or
environments, especially for mutations to highly pleiotropic genes with far-reaching effects. To
explore the universality of a growth benefit incurred by rpoAEVO we examined the effect of these
mutations under a number of different genetic backgrounds and growth environments.
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3.3.1. Mutations in rpoA Were Highly Beneficial in EM Grown on Methanol
Placed in the context of the ancestral, EM background, we found that both the rpoAF1 and rpoAF8
alleles substantially improve growth on methanol (Figure 3A). In fact, with respective increases of
57% and 61%, these F1 and F8 rpoA alleles are among the largest-effect beneficial mutations yet
discovered in this system. Importantly, our measurements of specific growth rate on methanol suggest
that these mutations are most important in the exponential phase of growth, and not necessarily for lag
or stationary phase. Thus, faced with a serious growth defect and a multitude of physiological
perturbations caused by the initial engineering of EM, evolved clones that acquired rpoAEVO would
have experienced a significant growth advantage over their cohorts, despite the highly pleiotropic
effect of these mutations. While further work is needed to understand the exact mechanism by which
rpoAEVO mutations are beneficial, microarray analysis points to uniquely expressed genes in F1 and F8
with functions in C1 metabolism, cellular replication, and the stress response. These mutations could
invoke in cells a response to “grow at all costs,” bypassing broad-level physiological mechanisms that
direct the cell to either grow and replicate or preserve resources for increased stress resistance and
survival [59].

Figure 3. Effect of rpoAEVO across multiple genetic backgrounds and growth conditions.
(A) Mutations to rpoA were highly beneficial in the ancestral, EM background.
(B) rpoAEVO mutations remained beneficial in presence of beneficial (fghAF4) mutations to
the engineered pathway. (C) rpoAEVO mutations were strongly deleterious in EM grown on
succinate. (D) The rpoAF8 allele was deleterious in the WT background grown on both
methanol and succinate. Repeated attempts to generate a WT strain possessing rpoAF1 failed.
Asterisk (*) indicates p < 0.05 in a two-tailed, unpaired t-test assuming unequal variance.
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3.3.2. Mutations in rpoA Remained Advantageous in the Context of Other Beneficial Mutations to the
Engineered Pathway
To begin to understand why such far-reaching, highly pleiotropic mutations are beneficial in this
system, we sought to test the effect of rpoAEVO in the presence of other beneficial mutations with
well-known physiological targets. To this end, we made mutational combinations with a
well-characterized mutation from our system—fghAF4—that provides a growth benefit by decreasing
the expression of the engineered formaldehyde oxidation pathway [25]. Combining mutations that both
decreased protein over-expression costs have been found to be less beneficial than when they were
present individually (i.e., antagonistic epistasis) [25,60]. We reasoned that if the physiological effects
of rpoAEVO were also focused to ameliorate the costs of expressing the foreign pathway, we should
observe a diminished selective benefit when rpoAEVO was combined with fghAF4 than when it
was alone.
Our results suggested that the rpoAEVO and fghAF4 mutations address largely different physiological
stressors/selective pressures in the evolved populations. We found that the presence of fghAF4 did not
obviate the selective benefit of rpoAEVO (and vice versa), as both mutations remained highly beneficial
in combination (Figure 3B). We did, however, observe some evidence of mutational interactions: The
benefit of rpoAF1 was reduced from 57% to 44% in the presence of fghAF4, indicative of “diminishing
returns” epistasis among beneficial mutations [25,61]; whereas the benefit of rpoAF8 was slightly
increased from 61% to 64%. Overall, however, these results show that the benefit of rpoAEVO was not
targeted specifically to optimize expression of the foreign pathway and plasmid.
3.3.3. Mutations in rpoA Were Deleterious in EM Grown on Succinate
Given the transcriptional pleiotropy of the rpoAEVO alleles, we sought to understand whether these
mutations remain advantageous on other growth substrates, particularly succinate. Metabolism of
succinate is very different than that of methanol, as it bypasses C1 enzymes to feed directly into the
TCA cycle [62,63], is under different regulatory control, and is thought to be limited by energy (ATP)
instead of reducing equivalents (NAD(P)(H)) [64].
Consistent with the idea that pleiotropy is often deleterious in alternative environments, we found
that rpoAEVO substantially hindered growth of EM on succinate. The F1 and F8 alleles reduced growth
by 67% and 46%, respectively (Figure 3C). These data corroborated prior observations that F1 isolates
are the worst on succinate, and actually worse than their EM ancestor, however F8 was not as nearly as
bad [25]. These results suggest that the benefit of rpoAEVO mutations do not extend to succinate growth
conditions, and could be specific to growth on methanol or C1 metabolism, in general.
3.3.4. Mutations in rpoA Are Deleterious in WT Grown on Methanol and Succinate
To further assess the pleiotropic effects of rpoAEVO, we sought to determine whether these alleles
remain beneficial in the context of the WT M. extorquens AM1 background. Despite numerous
attempts, we were unable to isolate WT: rpoAF1 clones through allelic exchange, and identified only a
handful of successful WT: rpoAF8 strains; far fewer than are normally found through this protocol.
Upon analyzing the growth of the latter strain on methanol, we observed that rpoAF8 is markedly
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deleterious (−25%) in the WT background (Figure 3D). This suggests that the underlying benefit of
rpoAEVO is highly specific—advantageous only to the physiology of the EM background grown on
methanol—and that the rpoAF1 and rpoAF8 mutations, despite their similarity, might invoke subtle yet
important allele-specific effects.
3.3.5. Mutations in rpoA Offer Protection against Hydrogen Peroxide Stress
A final test sought to determine whether rpoAEVO afforded cells increased protection against
oxidative stressors. One such stressor is formaldehyde, which is a necessary, albeit toxic, intermediate
in C1 metabolism that is rapidly produced during methylotrophic growth [65]. Any mechanisms that
help to regulate flux through formaldehyde and limit its toxicity are likely perturbed in EM, as
synthesis of the native carrier of formaldehyde (H4MPT) was abolished and the newly engineered
carrier (GSH) was diluted from its normal function to protect against oxidative stress. Microarray
analyses identified a number of genes involved in cell replication and the stress response that are
differentially expressed in EM relative to WT, or in rpoAEVO relative to rpoAWT strains. Thus, we
sought to test whether a general aspect of the benefit of rpoAEVO was by bolstering defenses against
oxidative stress.
We tested resistance to hydrogen peroxide (H2O2) using a disc assay in which a lawn of cells
suspended in soft agar were spread onto methanol agar plates with a small filter disc containing 5 μL
of 10 M hydrogen peroxide placed in the middle [47]. In control plates with no peroxide, all strains
produced a lawn of growth over the entire plate; however, in experimental plates, we observed a
well-defined zone of growth inhibition from H2O2-induced growth inhibition. The diameter of this
“dead zone” was measured and averaged over triplicate plates, and expressed relative to each strain’s
respective pink or white EM ancestor. One initial observation was that the pink and white EM
ancestors—which were used to prevent cross-contamination in the evolution experiments and were
shown to be neutral under standard growth conditions [25]—were, in fact, not equivalent under
peroxide duress. In fact, the carotenoids present in the pink-pigmented EM offered roughly 19% more
protection against peroxide than the otherwise isogenic white strain (Figure 4A). Moving forward,
each beneficial mutation was tested in the pink or white ancestor in which it arose, and normalized
relative to their specific ancestor.
Interestingly, we found that both rpoAEVO alleles, as well as a number of other mutations, offered a
protective effect against H2O2 stress. The evolved rpoA alleles from F1 and F8 offered roughly 5% and
15% more protection against peroxide than their respective pink and white EM ancestors (Figure 4B).
A number of other mutations, proven to be advantageous for growth, were also beneficial on hydrogen
peroxide, including mutations to the foreign pathway (fghA) and glutathione biosynthesis (gshA).
However, another mutation, kefBF8, was deleterious during H2O2 stress, reducing the growth zone by
23%. These results suggest that rpoAEVO may in part be advantageous for growth by helping to mount a
physiological response to oxidative stressors. Analysis of other beneficial mutations suggests that
increasing production of the GSH (gshA), or general improvements to decrease the metabolic burden
of bioengineering (fghA) can also offer increased resistance to H2O2, whereas mutations to pntAB and
kefB—both of which could alter the oxidative state of the cell via the flux of protons across the cell
membrane—are slightly to strongly deleterious under conditions of H2O2 stress.
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Figure 4. Stress test of rpoA and other mutants grown on methanol plates with hydrogen
peroxide. (A) Interestingly, pink and white EM ancestors were not equivalent in these
growth conditions, as the pink-pigmented strain with carotenoids was roughly 19% more
resistant against hydrogen peroxide. (B) Upon normalizing the growth of mutants to their
respective pink/white ancestor, several mutants—including rpoAEVO—offered protection
against hydrogen peroxide. Asterisk (*) indicates p < 0.05 in a two-tailed, unpaired
t test assuming unequal variance. Note that the gshAF4 allele imparted a marginally
insignificant reduction in inhibition (p = 0.056).
3.4. Complex Evolutionary Dynamics of rpoAEV°Mutations
Given that rpoAEVO mutations rose to an appreciable frequency (if not fixation) in F1 and F8
sampled at G600, we wondered whether similar mutations may have transiently appeared at earlier
time points in other F populations. We were particularly curious about a prior study examining allele
frequencies and clonal interference in population F4, in which a large number of mutants (14/72)
screened at G150 had none of the known, beneficial mutations that were present in the majority of the
population at G600 [66]. Using primers to amplify the linker region of rpoA, we found that each of
these 14 mutants shared a single novel, rpoAF4 allele that, like those in F1 and F8, extended the RpoA
linker domain by 141 bp, or 47 amino acids.
To better understand the evolutionary dynamics of these alleles, we compared the growth of
evolved clones possessing either rpoAEVO or rpoAWT in early populations of F1, F4, and F8. Prior work
in E. coli has shown that co-occurring lineages can have differential evolvability, such that a clone
from the “eventual winner” lineage was repeatedly able to adapt faster than a clone from the same time
point that was part of the “eventual loser” lineage [67]. In our populations, we know that lineages
containing rpoAEVO alleles were eventual winners in the F1 and F8 populations, but that the rpoAEVO
from F4 was an eventual loser. Using samples archived as a “living fossil record” for the F
populations, we were able to identify rpoAF1 clones at very early evolutionary time points, and chose
representative clones from each population with either rpoAEVO or rpoAWT to compare the performance
of these cohorts relative to EM, and to one another. Although the earliest evolved clones substantially
outperformed EM, the eventual fate of the lineages with or without rpoAEVO alleles was far from clear
at that point. Strains from F1 at G60 had very similar fitness regardless of the rpoA allele present,
whereas for the other two populations the isolate with an rpoAWT allele was faster than the one with
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rpoAEVO, despite the fact that in one population (F8) the rpoAEVO lineage overcame this disadvantage,
and in the other (F4) they were outcompeted by a lineage with an rpoAWT allele (Figure 5). This
suggests that rpoAEVO mutations arose in at least three F populations: Becoming fixed (or nearly so) in
F1 and F8, while rising to a fairly high frequency in F4 before losing out to other clonal lineages.
Given these complex dynamics, it is possible that still other rpoAEVO alleles experienced transient
success in the remaining F populations before going extinct, as has been seen for other loci [23].

Figure 5. Growth of rpoAEVO and rpoAWT cohorts sampled from early time points of
populations F1, F4, and F8. Contemporaneous evolved isolates possessing either rpoAEVO
or rpoAWT alleles were isolated from early F populations and assayed for their growth
improvements relative to EM on methanol. In all populations, evolved isolates with the
rpoAWT clones held a growth advantage over those with rpoAEVO present at the same time
point. Single and double asterisks indicate p < 0.05 in a two-tailed, unpaired t test assuming
unequal variance in comparing against EM (*) and early isolate cohorts (**), respectively.
4. Conclusions
The study of replicate, independently evolved populations of M. extorquens allowed us to identify
parallel evolutionary solutions in adapting to an engineered C1 metabolism. Repeatability of evolution
in the F isolates highlights common genetic solutions to relieve physiological stressors and
inefficiencies arising from the construction of EM, or from the evolution regime itself (i.e., cobalt
limitation). Interestingly, unlike other experiments where there were suites of mutations that occurred
together more commonly than by chance [68], thereby suggesting alternative mutational paths to
improvement, we did not observe any obvious patterns of this sort with our comparatively small
number of replicate populations. Furthermore, parallelism does not necessarily imply equivalency of
mutations. Take, for example, the four unique mutations that targeted the gshA locus: which varied not
only in the strength by which they increase gene expression, from 2.5-fold in F2 to 15.1-fold in F6; but
also in the scope of loci showing increased expression, from several loci upstream in F5, to several loci
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downstream in F3. While each of these alleles are sufficient to improve growth and physiology in the
eyes of natural selection, the bioengineer has the added fortune of applying post hoc analyses to
determine the optimal strength and scope of a mutational effect. The combined effects of a diversity of
targets and variation in the effect of evolved alleles may collectively explain the prior observation that
there was a far greater variance in fitness across these populations than commonly observed in
experimental evolution [23].
In the case of rpoA, we show that the scope of a mutation can sometimes reach to genome-wide
effects. Selected mutations that extended the linker domain of RpoA offered a massive growth benefit
in EM while helping to protect against oxidative stressors; however, given the central role of RNAP in
all of DNA transcription, they are likely to have far-reaching and possibly deleterious side effects.
Interestingly, major perturbations such as those from metabolic engineering or acute environmental
stress may place a premium on highly pleiotropic mutations that alter many aspects of physiology all at
once. Various evolution experiments in E. coli have yielded a number of similarly pleiotropic
mutations targeting components of RNAP, DNA replication, and other centrally-important
genes [68–71]. In addition to far-reaching physiological effects, highly pleiotropic mutations might
also have long-term consequences for evolution by creating selection for compensatory mutations, and
by perhaps limiting the rate at which further adaptations can accrue [67]. Whether or not these
limitations apply to bioengineering has yet to be shown. Yet, for all the potential drawbacks of highly
pleiotropic mutations to organismal physiology and long-term evolution, a mechanistic investigation of
why these mutations are beneficial can lead to more targeted solutions in strain optimization.
Overall, our work illustrates the benefits of using experimental evolution as a tool for biological
engineering. As long as the desired outcomes of metabolic engineering are tied to growth, natural
selection will quickly and efficiently enrich for mutants that are better able to grow and divide using
the engineered physiology. While these evolved populations and isolates might in themselves be of
use, the bioengineer is able to use whole-genome re-sequencing and assays of physiology to survey the
products of adaptation and identify and selectively combine those traits and alleles that are most
desirable. Mechanistic analyses of laboratory evolution can highlight the importance of genes that
were known a priori, as well as reveal novel genes and hidden physiological connections that might
not have been found through traditional engineering practices. By directly working to optimize the
growth and physiology of strains, “diagnosing” physiological stressors and inefficiencies, and offering
diverse solutions to these physiological challenges, experimental evolution is an invaluable tool for
bioengineering and the continued development of Methylobacterium-based biotechnology.
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